Cargando…
The use of carvone in consecutive patch testing
BACKGROUND: Carvone (l‐carvone) is a mint‐tasting flavour additive that most of us is exposed to and can cause allergic contact reactions. OBJECTIVES: To analyse the frequency and the relevance of positive carvone reactions in a dermatitis population. METHOD: A retrospective analysis of dermatitis p...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098734/ https://www.ncbi.nlm.nih.gov/pubmed/36399045 http://dx.doi.org/10.1111/cod.14249 |
_version_ | 1785024881182638080 |
---|---|
author | Enberg, Johanna Hamnerius, Nils Kroona, Liv Svedman, Cecilia |
author_facet | Enberg, Johanna Hamnerius, Nils Kroona, Liv Svedman, Cecilia |
author_sort | Enberg, Johanna |
collection | PubMed |
description | BACKGROUND: Carvone (l‐carvone) is a mint‐tasting flavour additive that most of us is exposed to and can cause allergic contact reactions. OBJECTIVES: To analyse the frequency and the relevance of positive carvone reactions in a dermatitis population. METHOD: A retrospective analysis of dermatitis patients consecutively tested with carvone from 2017 to 2021. Data were retrieved from the department's patch‐test database. RESULTS: Of 3554 patients tested with carvone, 28 (0.79%) had a positive reaction. Carvone‐positive patients had higher mean age, were significantly more likely female (p < 0.001) and had often an intraoral/lip involvement (p < 0.001). In the carvone‐positive group, 50% (n = 14) had a relevant reaction, and in 4 of 14, the relevance was first revealed after test reading. Of the carvone‐positive patients, 18 of 28 did not have a coexisting allergy to a fragrance/flavour allergen and of these 44% had a relevant allergy. CONCLUSIONS: The study suggests that a significant fraction of relevant carvone contact allergies may be overlooked if the allergen is not tested. Furthermore, as the exposure is widespread, inclusion of carvone in the Swedish baseline series may be justified even if the contact allergy prevalence is below 1%. |
format | Online Article Text |
id | pubmed-10098734 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-100987342023-04-14 The use of carvone in consecutive patch testing Enberg, Johanna Hamnerius, Nils Kroona, Liv Svedman, Cecilia Contact Dermatitis Original Articles BACKGROUND: Carvone (l‐carvone) is a mint‐tasting flavour additive that most of us is exposed to and can cause allergic contact reactions. OBJECTIVES: To analyse the frequency and the relevance of positive carvone reactions in a dermatitis population. METHOD: A retrospective analysis of dermatitis patients consecutively tested with carvone from 2017 to 2021. Data were retrieved from the department's patch‐test database. RESULTS: Of 3554 patients tested with carvone, 28 (0.79%) had a positive reaction. Carvone‐positive patients had higher mean age, were significantly more likely female (p < 0.001) and had often an intraoral/lip involvement (p < 0.001). In the carvone‐positive group, 50% (n = 14) had a relevant reaction, and in 4 of 14, the relevance was first revealed after test reading. Of the carvone‐positive patients, 18 of 28 did not have a coexisting allergy to a fragrance/flavour allergen and of these 44% had a relevant allergy. CONCLUSIONS: The study suggests that a significant fraction of relevant carvone contact allergies may be overlooked if the allergen is not tested. Furthermore, as the exposure is widespread, inclusion of carvone in the Swedish baseline series may be justified even if the contact allergy prevalence is below 1%. Blackwell Publishing Ltd 2022-11-25 2023-03 /pmc/articles/PMC10098734/ /pubmed/36399045 http://dx.doi.org/10.1111/cod.14249 Text en © 2022 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Enberg, Johanna Hamnerius, Nils Kroona, Liv Svedman, Cecilia The use of carvone in consecutive patch testing |
title | The use of carvone in consecutive patch testing |
title_full | The use of carvone in consecutive patch testing |
title_fullStr | The use of carvone in consecutive patch testing |
title_full_unstemmed | The use of carvone in consecutive patch testing |
title_short | The use of carvone in consecutive patch testing |
title_sort | use of carvone in consecutive patch testing |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098734/ https://www.ncbi.nlm.nih.gov/pubmed/36399045 http://dx.doi.org/10.1111/cod.14249 |
work_keys_str_mv | AT enbergjohanna theuseofcarvoneinconsecutivepatchtesting AT hamneriusnils theuseofcarvoneinconsecutivepatchtesting AT kroonaliv theuseofcarvoneinconsecutivepatchtesting AT svedmancecilia theuseofcarvoneinconsecutivepatchtesting AT enbergjohanna useofcarvoneinconsecutivepatchtesting AT hamneriusnils useofcarvoneinconsecutivepatchtesting AT kroonaliv useofcarvoneinconsecutivepatchtesting AT svedmancecilia useofcarvoneinconsecutivepatchtesting |